Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

被引：0

作者：

Ryoki Hara

Hiroaki Umebayashi

Syuji Takei

Nami Okamoto

Naomi Iwata

Yuichi Yamasaki

Yasuo Nakagishi

Toshitaka Kizawa

Ichiro Kobayashi

Tomoyuki Imagawa

Noriko Kinjo

Norihito Amano

Yoko Takahashi

Masaaki Mori

Yasuhiko Itoh

Shumpei Yokota

机构：

[1] Yokohama City University School of Medicine,Department of Pediatrics

[2] Miyagi Children’s Hospital,Department of General Pediatrics

[3] 4-3-17 Ochiai,Department of Pediatrics

[4] Kagoshima University Medical and Dental Hospital,Department of Pediatrics

[5] Graduate School of Medicine,Department of Immunology and Infectious Diseases

[6] Osaka Medical College,Department of Pediatric Rheumatology

[7] Aichi Children’s Health and Medical Center,Department of Pediatrics

[8] Hyogo Prefectural Kobe Children’s Hospital,Department of Pediatrics

[9] Japan Community Health Care Organization Sapporo Hokushin Hospital,Division of Infection, Immunology and Rheumatology

[10] Hokkaido University Hospital,Department of Pediatrics

[11] Kanagawa Prefectural Hospital Organisation Kanagawa Children’s Medical Center,Bristol

[12] University of the Ryukyus Hospital,Myers Squibb K.K

[13] 6-5-1 Nishi-Shinjuku,Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences

[14] Tokyo Medical and Dental University,Department of Pediatrics

[15] Graduate School of Medicine,undefined

[16] Nippon Medical School,undefined

[17] Fuji Toranomon Orthopaedics Hospital,undefined

来源：

Pediatric Rheumatology | / 17卷

关键词：

Abatacept; Disease-modifying anti-rheumatic drugs (DMARDs); Japanese; Juvenile idiopathic arthritis; Pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Open-label Phase 3 Study of Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Pharmacokinetics, Effectiveness, Safety, and Immunogenicity over 252 Weeks
Ruperto, Nicolino
Lovell, Daniel J.
Ringold, Sarah
Xu, Xie L.
Leu, Jocelyn H.
Lam, Edwin
Wang, Yuhua
Martini, Alberto
Brunner, Hermine
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 695 - 696
[22] Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study
Ruperto, Nicolino
Lovell, Daniel J.
Berman, Alberto
Avila-Zapata, Francisco
Horneff, Gerd
Alessio, Maria
Becker, Mara L.
Belot, Alexandre
Burgos-Vargas, Ruben
Gamir, Maria L.
Goldenstein-Schainberg, Claudia
Scheibel, Iloite M.
Terreri, Maria T.
Zemel, Lawrence
Zhuo, Joe
Askelson, Margarita
Wong, Robert
Martini, Alberto
Brunner, Hermine I.
ARTHRITIS CARE & RESEARCH, 2023, : 1804 - 1814
[23] GROWTH DURING TOCILIZUMAB THERAPY IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM THE PHASE III CHERISH TRIAL
Ramanan, Athimalaipet
Bharucha, Kamal N.
Brunner, Hermine I.
Ruperto, Nicola
Cabral, David A.
Gedalia, Abraham
Gerloni, Valeria
Jorgensen, Christian
Lovell, Daniel J.
Martini, Alberto
Frane, Jim
Wells, Chris
De Benedetti, Fabrizio
RHEUMATOLOGY, 2015, 54 : 157 - 158
[24] A Multi-Center, Open-Label Study to Assess the Pharmacokinetics, Efficacy and Safety of Certolizumab Pegol in Children and Adolescents with Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis: Week 24 Results
Brunner, Hermine I.
Ruperto, Nicolino
Keltsev, Vladimir
Alexeeva, Ekaterina
Abud-Mendoza, Carlos
Schmeling, Heinrike
Del Rocio Maldonado-Velazquez, Maria
Rubio-Perez, Nadina
Stanislav, Marina
Chasnyk, Vyacheslav
Brown, Diane
Henrickson, Michael
Kingsbury, Daniel
Rabinovich, C. Egla
Zeft, Andrew
Silverman, Earl
Wang, Maggie
Charlton, Philippa
Lledo-Garcia, Rocio
Shaughnessy, Laura
Lovell, Daniel J.
Martini, Alberto
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[25] Effect of Immunogenicity on Efficacy and Safety of Subcutaneous or Intravenous Abatacept in Pediatric Patients with Polyarticular-Course JIA: Findings from Two Phase III Trials
Brunner, Hermine
Tzaribachev, Nikolay
Louw, Ingrid
Berman, Alberto
Calvo Penades, Inmaculada
Anton, Jordi
Avila-Zapata, Francisco
Cuttica, Ruben J.
Horneff, Gerd
Wong, Robert
Shaikh, Mehmooda
Mora, Johanna
Nys, Marleen
Lovell, Daniel J.
Martini, Alberto
Ruperto, Nicolino
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[26] Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Brunner, Hermine I.
Ruperto, Nicolino
Zuber, Zbigniew
Keane, Caroline
Harari, Olivier
Kenwright, Andrew
Lu, Peng
Cuttica, Ruben
Keltsev, Vladimir
Xavier, Ricardo M.
Calvo, Inmaculada
Nikishina, Irina
Rubio-Perez, Nadina
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Silva, Clovis A.
Silverman, Earl
Spindler, Alberto
Baildam, Eileen
Luz Gamir, M.
Martin, Alan
Rietschel, Christoph
Siri, Daniel
Smolewska, Elzbieta
Lovell, Daniel
Martini, Alberto
De Benedetti, Fabrizio
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1110 - 1117
[27] Sarilumab, a Human Monoclonal Antibody to the Interleukin-6 Receptor, in Polyarticular-course Juvenile Idiopathic Arthritis: A 12-week, Multinational, Open-label, Dose-finding Study
De Benedetti, Fabrizio
Calvo Penades, Inmaculada
Rubio-Perez, Nadina
Maschan, Alexey
Quartier, Pierre
Zuber, Zbigniew
Stanislav, Marina
Barria, Raul
Clemente, Daniel
Vega-Cornejo, Gabriel
Liu, Nancy
Xu, Christine
Giannelou, Angeliki
Akinlade, Bolanle
Baret-Cormel, Lydie
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[28] Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
Bharucha, Kamal N.
Brunner, Hermine I.
Calvo Penades, Inmaculada
Nikishina, Irina
Rubio-Perez, Nadina
Oliveira, Sheila
Kobusinska, Katarzyna
Schmeling, Heinrike
Sztajnbok, Flavio
Weller-Heinemann, Frank
Zholobova, Elena
Zulian, Francesco
Allen, Roger
Chaitow, Jeffrey
Frane, James
Wells, Chris
Ruperto, Nicolino
De Benedetti, Fabrizio
JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1173 - 1179
[29] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Violetta Opoka-Winiarska
Zbigniew Żuber
Ekaterina Alexeeva
Vyacheslav Chasnyk
Irina Nikishina
Grażyna Dębowska
Elżbieta Smolewska
Clinical Rheumatology, 2018, 37 : 1807 - 1816
[30] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Opoka-Winiarska, Violetta
Zuber, Zbigniew
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Nikishina, Irina
Debowska, Grazyna
Smolewska, Elzbieta
CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816

← 1 2 3 4 5 →